Oncology Products &
Prescribing Information

Cancer is one of the world's most urgent unmet medical needs.

Helping people fight cancer is our passion. We are committed to developing breakthrough biomedical innovations to help extend and improve the lives of people with cancer worldwide.

EMEND®

(aprepitant) capsules
(aprepitant) for oral suspension

Prescribing Information
Patient Product Information
Instructions for Use
Product website

EMEND®

(fosaprepitant dimeglumine) for injection, for intravenous use

Prescribing Information (5.4 mg EDTA formulation)
Prescribing Information (18.8 mg EDTA formulation)
Patient Product Information

INTRON® A

Interferon alfa-2b, recombinant For Injection

Prescribing Information (5 mL diluent)
Medication Guide
Instructions for Use - Powder for Solution (5 mL diluent)
Instructions for Use – Solution for Injection
Product website

KEYTRUDA® (pembrolizumab) for injection, for intravenous use
KEYTRUDA® (pembrolizumab) injection, for intravenous use
Prescribing Information
Medication Guide
Product website

SYLATRON

(peginterferon alfa-2b) for Injection, for subcutaneous use

Prescribing Information (5 mL diluent)
Medication Guide
Instructions for Use (5 mL diluent)

TEMODAR® Capsules

(temozolomide)

Prescribing Information
Patient Product Information
Pharmacist Information

TEMODAR® for Injection

(temozolomide)

Prescribing Information
Patient Product Information
Pharmacist Information

TICE® BCG

BCG LIVE (FOR INTRAVESICAL USE)

Prescribing Information
ZOLINZA®

(vorinostat) Capsules

Prescribing Information
Patient Product Information

MERCK ONCOLOGY CLINICAL TRIALS

Learn more

MERCK'S INVESTIGATIONAL MEDICINES ACCESS POLICY

Learn more

Need Help Paying for your Medicines and Vaccines?

Learn more

REPORT ADVERSE EXPERIENCE

To report an adverse experience with a specific Merck product, please call the Merck National Service Center at 800-444-2080